Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines (Q38746127)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 September 2016

Language	Label	Description	Also known as
English	Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines	scientific article published on 08 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Zong-Yang Li

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Qing-Zhong Li

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Lei Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Bao-Dong Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Bo Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xie-Jun Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Wei-Ping Li

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

8 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Neurochemical Research

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

3192-3205

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

NF-kappaB and STAT3 signaling in glioma: targets for future therapies

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Regulation of NF-κB Action by Reversible Acetylation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Good cop, bad cop: the different faces of NF-kappaB

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Transcriptional activation by NF-kappaB requires multiple coactivators

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Duration of nuclear NF-kappaB action regulated by reversible acetylation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Histone deacetylase: a regulator of transcription

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Identification of novel isoform-selective inhibitors within class I histone deacetylases

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Stimulus specificity of gene expression programs determined by temporal control of IKK activity

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Histone acetyltransferases

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

The regulation of gene activity by histones and the histone deacetylase RPD3.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Function of the ING family of PHD proteins in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Biological functions of the ING family tumor suppressors

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Nuclear localization signal of ING4 plays a key role in its binding to p53.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-2043-5

21 January 2018

Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2

1 reference

https://pubmed.ncbi.nlm.nih.gov/27632183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/27632183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression

1 reference

https://pubmed.ncbi.nlm.nih.gov/27632183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27632183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of NF-kappaB action by reversible acetylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27632183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11064-016-2043-5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38746127&oldid=2202033055"